Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters











Database
Language
Publication year range
1.
J Ethnopharmacol ; 131(2): 425-32, 2010 Sep 15.
Article in English | MEDLINE | ID: mdl-20633627

ABSTRACT

ETHNOPHARMACOLOGICAL RELEVANCE: Hofmeisteria schaffneri (Asteraceae) is a medicinal plant widely commercialized in the most important Markets of Mexico City for the treatment of gastro-intestinal complaints and skin afflictions. AIM OF THE STUDY: The main goals of this study were to establish the potential acute toxicity and the antinociceptive activity in animal models of several preparations and compounds from Hofmeisteria schaffneri. MATERIALS AND METHODS: The aqueous and organic extracts as well as the essential oil of Hofmeisteria schaffneri were prepared by infusion, maceration and hydrodistillation, respectively. Investigation of the acute toxicity was accomplished by the Lorke method. The antinociceptive effect was assessed using the writhing and the hot plate tests. Natural compounds were isolated by standard phytochemical procedures. In addition, a few thymol esters were prepared by chemical synthesis. The stability of natural and synthetic esters was qualitatively analyzed by measuring their susceptibility to hydrolysis by pig liver estearase and mouse plasma at 37 degrees C. RESULTS: The LD(50) for each preparation tested was higher than 5000 mg/kg revealing that they were not toxic to mice after exposure for short space of time. On the other hand, the extracts showed significant antinociceptive effect when tested in the hot plate model. The most active natural product as antinociceptive agent was hofmeisterin III (1) which also was the most stable in the stability study. Its pharmacological effect seems to be partially mediated by an opioid mechanism since naloxone inhibits its action. Using compound 1 as a lead molecule, several synthetic thymol esters were prepared and only compounds 13, 15 and 17 were antinoceptive at the dose of 1 mg/kg. CONCLUSIONS: The present investigation provided evidence of the efficacy of several preparations of Hofmeisteria schaffneri as antinociceptive agents. The most active preparation was the essential oil which contained large amount of hofmeisterin III (1) and other thymol derivatives. Some novel synthetic analogs of hofmeisterin III with antinociceptive properties were discovered. The nature of the ester chain of these analogs did not have a clear impact on the antinociceptive activity. The phyto-preparations analyzed in this study were not toxic to mice according to the Lorke's test; therefore considering their long term use of the plant they might be secure for human consumption.


Subject(s)
Analgesics/therapeutic use , Asteraceae/chemistry , Narcotic Antagonists/therapeutic use , Oils, Volatile/therapeutic use , Pain/drug therapy , Phytotherapy , Plant Extracts/therapeutic use , Analgesics/pharmacology , Analgesics/toxicity , Animals , Hot Temperature , Lethal Dose 50 , Male , Mice , Mice, Inbred ICR , Naloxone/pharmacology , Narcotic Antagonists/pharmacology , Narcotic Antagonists/toxicity , Oils, Volatile/chemistry , Oils, Volatile/pharmacology , Plant Components, Aerial , Plant Extracts/chemistry , Plant Extracts/pharmacology , Plant Extracts/toxicity , Thymol/pharmacology , Thymol/therapeutic use
2.
Neurosci Lett ; 441(3): 315-8, 2008 Aug 29.
Article in English | MEDLINE | ID: mdl-18601977

ABSTRACT

Naloxone is an opioid receptor antagonist with effects on the EEG and behavior in animals and humans and has been used clinically in drug-abuse treatment. The goal of this work in the rat is to determine whether treatment with naloxone during the suckling period would influence the propagation of cortical spreading depression (CSD), both in weaned young and adult animals. From the 7th to the 28th postnatal day, male rat pups were treated daily with a single subcutaneous injection of either 10mg/kg/d naloxone (n=21 rats) or equivalent volume (10ml/kg) of saline (n=16). In both treatment conditions, when the pups were 30-40 days- (young groups; 9 Naloxone- and 10 saline-treated rats), or 90-120-days old (adult groups; 12 Naloxone- and 6 saline-treated rats), a 4h CSD recording session was performed with electrodes at two points at a fixed distance apart on the parietal cortical surface. CSD propagation velocity was calculated based on the time spent for a CSD-wave to pass between the electrodes. In both young- and adult groups, naloxone-treated animals displayed lower CSD velocities (P<0.05) than the corresponding saline injected animals. Our results demonstrate, for the first time, that chronic neonatal exposure of rats to the opioid antagonist naloxone results in an impairing propagation of the CSD that is long lasting, suggesting the existence of one or more opioid-mediated processes influencing CSD.


Subject(s)
Brain/drug effects , Brain/physiopathology , Cortical Spreading Depression/drug effects , Naloxone/toxicity , Narcotic Antagonists/toxicity , Action Potentials/drug effects , Action Potentials/physiology , Aging/drug effects , Aging/metabolism , Animals , Animals, Newborn , Animals, Suckling/growth & development , Animals, Suckling/metabolism , Brain/growth & development , Chronic Disease , Cortical Spreading Depression/physiology , Disease Models, Animal , Drug Administration Schedule , Male , Opioid Peptides/metabolism , Opioid-Related Disorders/drug therapy , Opioid-Related Disorders/metabolism , Opioid-Related Disorders/physiopathology , Rats , Rats, Wistar , Time
SELECTION OF CITATIONS
SEARCH DETAIL